OBJECTIVES: Intraoperative hypoxaemia during one-lung ventilation (OLV) remains a major concern in thoracic surgery. Non-intubated video-assisted thoracic surgery (VATS) involves a greater risk of consequent emergent conversion to endotracheal intubation. Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) has recently been reported to be beneficial for higher oxygen reserves during difficult intubations and for enhancing postoperative recovery after thoracic surgery. However, the effects of THRIVE on oxygenation and carbon dioxide elimination before and during OLV in non-intubated VATS have not been investigated.
INTRODUCTION
Non-intubated video-assisted thoracic surgery (VATS) is widely used to ensure acceptable postoperative outcomes with preserved respiratory function and without residual muscle relaxation and airway trauma [1, 2] . In contrast to the potential adverse effects of intubated general anaesthesia, non-intubated VATS may result in a more complete physiological, immunological and neuromuscular recovery after surgery, reducing morbidity and, thereby, shortening hospital stays [3] [4] [5] .
During non-intubated VATS, the operative lung collapses naturally after the creation of artificial pneumothorax during spontaneous ventilation and following one-lung ventilation (OLV).
However, the risks of hypoxaemia and hypercapnia remain during OLV. Intractable hypoxaemia will require emergent conversion to intubated general anaesthesia [6] . The conversion rate was found to be 3-10% with respect to the extent of the surgical procedures, of which 14-33% were a result of persistent hypoxaemia [7, 8] .
Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) has been reported to provide a larger oxygenation reserve and more effective carbon dioxide (CO 2 ) elimination recently [9] . It has been successfully applied to cases of prolonged difficult intubation and intensive respiratory care in patients receiving abdominal surgical procedures and VATS lobectomy postoperatively [10] [11] [12] . In theory, THRIVE is beneficial during OLV for both oxygenation and CO 2 elimination because it provides a strong flow of oxygen and continuous positive airway pressure therapy to the dependent lung [13, 14] and reduces respiratory dead space because of the high flow of oxygen [15] . However, the effect of THRIVE on oxygenation and CO 2 elimination during OLV under spontaneous breathing in non-intubated VATS has not been investigated.
Since September 2016, our team has applied THRIVE to nonintubated VATS and determined that it provides a surgical field similar to that of conventional oxygen masks (Video 1). We hypothesized that the use of THRIVE in non-intubated VATS is associated with superior preoperative and intraoperative arterial oxygenation and higher CO 2 elimination before and during OLV.
MATERIALS AND METHODS
This study was reviewed and approved by the Research Ethics Committee of National Taiwan University Hospital, Taipei, Taiwan (201701118RINC). A prospectively collected database of patients who received non-intubated VATS has been maintained since we began non-intubated VATS in August 2009. In addition, THRIVE has been applied in non-intubated VATS since September 2016. According to a pilot study of preoperative 100 mmHg arterial oxygen tension (P a O 2 ) difference between the application of THRIVE and oxygen masks, the sample size was estimated to be over 22 patients in each group with a Type I error of 0.05 and a Type II error of 0.1 at 1:1 ratio. We collected data on 30 consecutive patients who underwent non-intubated VATS with THRIVE as part of our retrospective study to compare with patients with oxygen masks as historically controlled group between September 2015 and July 2016. A single thoracic surgical team performed all surgical procedures using identical clinical protocols, care patterns and perioperative orders.
Criteria for patient selection for non-intubated video-assisted thoracic surgery
Patients who met the following criteria were considered candidates for non-intubated VATS: tumours smaller than 6 cm, peripheral lesions, no evidence of severe adhesion and no evidence of chest wall, diaphragm or main bronchus involvement. Patients who had potential or confirmed airway complications, morbid obesity (body mass index >35 kg/m 2 ), coagulopathy, anatomical deformity or an American Society of Anesthesiology (ASA) classification >3 were excluded.
Propensity score matching
The variables for the propensity score matching were chosen by first performing a logistic regression of THRIVE versus oxygen mask on the following factors: age (years), gender, body mass index, ever smoker (yes or no), prior cancer history (yes or no) and anatomical resection (yes or no). The propensity score was calculated, and patients of both groups were matched 1:1 using the nearest neighbour matching algorithm. A retrospective data set including 30 patients who underwent non-intubated VATS maintained with THRIVE and 77 patients with an oxygen mask was used to identify matched THRIVE and oxygen mask cohorts, and 30 pairs were matched. Patient demographic characteristics for the matched groups are listed in Table 1 .
Protocol for non-intubated video-assisted thoracic surgery maintained with oxygen masks All patients were preoxygenated using oxygen masks at a flow of 10 l/min before anaesthesia. We used pulse oximeters, electrocardiography, blood pressure and frontal bispectral index (BIS Quatro; Aspect Medical System, Norwood, MA, USA) to monitor the patients. A detector was placed in front of the mouth to monitor end-tidal carbon dioxide (ETCO 2 ) (Fig. 1) . The patients were premedicated with 50 lg of intravenous fentanyl and then sedated with intravenous propofol using a targeted control infusion (Injectomat V R TIVA Agilia; Fresenius Kabi GmbH, Graz, Austria), as previously described [16] . The level of sedation was maintained at a bispectral index (BIS) value of 40-60. An arterial catheter was placed for haemodynamic monitoring and arterial blood gas analysis. The patients were placed in a lateral decubitus position for thoracoscopic surgery. Incremental fentanyl injection was provided to limit the respiratory rate to less than 20 breaths/min. Oxygen flow was limited to 10 l/min to maintain oxygenation in the oxygen mask group throughout the procedure, including during OLV. Baseline arterial blood gas measurements were performed after induction, and a BIS value of 40-60 was achieved.
Protocol for non-intubated video-assisted thoracic surgery maintained with transnasal humidified rapid-insufflation ventilatory exchange All patients were preoxygenated with THRIVE, initially at a flow of 20 l/min before anaesthesia. The anaesthetic setting and monitoring were similar to those of the group with oxygen masks except for oxygen flow (Fig. 2) . The THRIVE oxygen flow was temporarily suspended immediately before iatrogenic pneumothorax and was resumed after the OLV completion was confirmed by the surgeon.
Surgical technique
The first incision was created after local anaesthetic infiltration with 1% lidocaine at the fifth intercostal space and following iatrogenic pneumothorax. Intrathoracic intercostal nerve and vagal blocks were performed using 0.5% bupivacaine under thoracoscopy, as previously described [16] . Additional working ports may be required according to the position of the tumours. Arterial blood gas during OLV was measured 20-25 min after OLV commenced.
At the end of the procedure, the collapsed lung was recruited in the THRIVE group with a high flow of oxygen at 70 l/min to check for air leakage through thoracoscopic observation. In the oxygen mask group, the operative lung was expanded through manually assisted mask ventilation.
Data collection and statistical analysis
Demographic data and operation outcomes were obtained from the patient chart review. The anaesthesia data, including pulse oximeter, ETCO 2 , preoperative arterial blood gas and arterial blood gas during OLV, were obtained from the anaesthetic records. Statistical analysis was performed using Stata SE 14.2 (Stata Corp., College Station, TX, USA). Categorical data were analysed using the Fisher's exact test. Numerical data were presented as means ± standard deviation, unless otherwise specified. The Student's t-test was performed to compare the sample means. The 2-sample Wilcoxon rank-sum (Mann-Whitney) test was performed to compare the lowest pulse oxygen saturations between the 2 groups. Two-way analysis of variance was applied to detect the effect of OLV on P a O 2 and arterial carbon dioxide tension (P a CO 2 ) of the THRIVE and the mask groups. A P-value of <0.05 was considered significantly different.
RESULTS
The demographic data of the 2 groups are summarized in Table 1 . The thoracoscopic procedures performed on both groups are presented in Table 2 . Patients in each group did not differ significantly in terms of gender, age, height, body mass index, smoking status, preoperative pulmonary function tests, pathological diagnosis, comorbidity, tumour size, ASA classification or the type of procedure performed.
The effects of THRIVE and oxygen mask on arterial oxygenation and gas exchange in non-intubated VATS are shown in Fig.  3 . The THRIVE group exhibited a significantly higher mean P a O 2 in the preoperative period and during OLV than the oxygen mask group (preoperative: 416.0 vs 265.9 mmHg, P < 0.01; onelung breathing: 207.0 vs 127.8 mmHg, P = 0.01). During surgery, the mean lowest oxygen saturation was also higher in the THRIVE group than in the oxygen mask group (98 vs 95%, P = 0.04). Moreover, the mean P a CO 2 was not different between the THRIVE group and the oxygen mask group (preoperative: 48.0 vs 46.2 mmHg, P = 0.29; one-lung breathing: 49.4 vs 49.6 mmHg, P = 0.93). The detectable mean highest ETCO 2 was not significantly different between the THRIVE group and the oxygen mask group (39.3 vs 36.9 mmHg, P = 0.24). Regarding the changes in P a O 2 during OLV in each group, OLV induced a significant decrease in P a O 2 (P < 0.01), but no statistically significant interaction occurred between group and OLV (P = 0.08). Regarding the changes in P a CO 2 during OLV, there were no statistically significant differences between the 2 groups (P = 0.08). There was no episodes of lower pulse oxygen saturation (<90%) in the THRIVE group, while 8 patients in the oxygen mask group experienced lower oxygen saturation and did not sustain this for more than 5 min.
The perioperative results and treatment outcomes are presented in Table 3 . The THRIVE group had a significantly longer mean induction time (12.8 vs 9.5 min, P = 0.02). The median postoperative length of stay was similar between the THRIVE group and the oxygen mask group. The proportion of patients who were free of complications was similar in the 2 groups. Two complications developed in the THRIVE group (7%), including 1 patient who had urinary retention and 1 patient who had vomiting requiring medicine, whereas 3 complications developed in the oxygen mask group (10%), including 1 patient who had air leakage, 1 patient who had pneumonia and 1 patient who had vomiting requiring medicine. There was no perioperative mortality in either group.
DISCUSSION
In this study, we demonstrated that THRIVE not only provided significantly higher oxygenation for anaesthetic induction but also provided higher oxygenation during OLV than conventional oxygen masks. Our results indicated that THRIVE provides higher oxygenation and increases the margin of safety in BIS-targeted intravenous anaesthesia, similarly to a previous study [17] . Our results suggested that with unavoidable rapid and significant deterioration of oxygenation during OLV, THRIVE with 20 l/min of oxygen flow is feasible for successful non-intubated VATS and beneficial for providing a larger oxygen reserve during OLV. Without expanding the collapsed lung with 20 l/min of oxygen flow, using THRIVE increases the safety margin during OLV. Lung collapse can be easily achieved by turning the oxygen flow of THRIVE down immediately before the start of artificial pneumothorax. After complete lung collapse has been achieved, the oxygen flow can be resumed without re-expanding the collapsed lung. With a flow rate of 20 l/min using THRIVE, there may be a continuous positive airway pressure effect on both the ventilated and the non-dependent lungs during OLV [13] . Moreover, high-flow oxygen of up to 70 l/min can be applied to recruit the collapsed lung at the end of surgery and can be easily video monitored [18] . To prevent the collapsed lung from reinflating, this very high oxygen flow rate is best avoided during OLV in non-intubated VATS. We only used a flow rate of 70 l/min to recruit the collapsed lung at the end of surgery, which is best avoided during OLV.
Nasal high-flow oxygen was reported to reduce tissue CO 2 without increasing the respiratory rate [19] by eliminating the anatomical dead space in the upper airway [15] . However, in our study, comparable P a CO 2 was found in both groups and either before or during OLV. With comparable BIS levels, the production of CO 2 or minute ventilation is similar between the 2 groups. Our results demonstrated that THRIVE at an oxygen flow rate of 20 l/min did not affect the CO 2 elimination before and during OLV. Because the clearance of dead space is associated with higher flow rates and the very high oxygen flow is best avoided to prevent the collapsed lung from reinflating, the use of THRIVE is not better for CO 2 elimination during OLV in non-intubated VATS. Although the ETCO 2 data were comparable, ETCO 2 is not a useful indicator of P a CO 2 when high flow is delivered through THRIVE [20] .
When applying THRIVE in non-intubated operations, another concern regarding airway protection from aspiration is that highflow oxygen causes gastric distension. The risk is not high, in theory, for the airway pressure generated when using high-flow oxygen in healthy volunteers [13] ; indeed, the risk is relatively low compared with the pressure maintained by lower oesophageal sphincter [21] . High-flow oxygen was reported not to be inferior to other positive airway pressure devices regarding adverse effects [22] and increases in middle ear pressure [23] . However, we do not recommend non-intubated surgery for patients with symptomatic gastro-oesophageal reflux or inadequate fasting status.
Limitations
We acknowledge that this study was retrospective and that the comparison was based on historical controls. We have attempted to directly address this fundamental limitation with the use of propensity matching and a quasi-experimental analysis. Further randomized trials are necessary to confirm the benefits of nonintubated VATS applying THRIVE compared with non-intubated surgery using an oxygen mask and intubated general anaesthesia. Researchers are encouraged to conduct more clinical studies to address solid evidence of other variables for side effects or improvement of recovery.
CONCLUSION
In summary, our study demonstrated that non-intubated VATS using THRIVE is feasible and safe. With a larger safety margin during OLV, the application of THRIVE can make non-intubated VATS safer and more attractive if THRIVE is incorporated into a minimally invasive surgical approach. The results indicated that THRIVE is easy and economically beneficial during continuous postoperative respiratory care. 
